LB929 Opioid use disorder in a cohort of hidradenitis suppurativa patients

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease. While HS treatment consists of a multi-tiered approach, many patients also seek therapy for debilitating pain. An increased risk of long-term opioid use disorder (OUD) has been intensively explored in patients with HS; however, there is a paucity of information associated with ‘screening’ for OUD. The Prescription Opioid Misuse Index (POMI), a 6-point questionnaire, is a specific and sensitive instrument for identifying patients with OUD.